{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:20:15Z","timestamp":1789885215915,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jviromet.2019.01.001","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T20:48:38Z","timestamp":1546548518000},"page":"9-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Comparative analysis of the performance of residual host cell DNA assays for viral vaccines produced in Vero cells"],"prefix":"10.1016","volume":"268","author":[{"given":"Olivier","family":"Vernay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3794-2371","authenticated-orcid":false,"given":"Eric","family":"Sarcey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Detrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Abachin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Riou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2650-1228","authenticated-orcid":false,"given":"B\u00e9n\u00e9dicte","family":"Mouterde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Bonnevay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2019.01.001_bib0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biologicals.2016.03.002","article-title":"Universal real-time PCR assay for quantitation and size evaluation of residual cell DNA in human viral vaccines","volume":"44","author":"Andre","year":"2016","journal-title":"Biologicals"},{"key":"10.1016\/j.jviromet.2019.01.001_bib0010","series-title":"Chapter 3407. Determination of Residual Extraneous DNA","author":"Chinese Pharmacopoeia","year":"2015"},{"key":"10.1016\/j.jviromet.2019.01.001_bib0015","series-title":"European Medicines Evaluation Agency. CPMP\/BWP\/382\/97 \u2013 CPMP Position Statement on DNA and Host Cell Proteins (HCP) Impurities, Routine Testing Versus Validation Studies","author":"EMEA","year":"1997"},{"key":"10.1016\/j.jviromet.2019.01.001_bib0020","series-title":"European Medicines Evaluation Agency. CPMP\/BWP\/1143\/00 - CPMP Position Statement on the Use of Tumorigenic Cells of Human Origin for the Production of Biological and Biotechnological Medicinal Products","author":"EMEA","year":"2001"},{"key":"10.1016\/j.jviromet.2019.01.001_bib0025","series-title":"General Chapter 5.2.3. Cell Substrates for the Production of Vaccines for Human Use. Strasbourg, France","author":"European Pharmacopoeia","year":"2018"},{"key":"10.1016\/j.jviromet.2019.01.001_bib0030","series-title":"Monograph 0214. Poliomyelitis Vaccine (inactivated). Strasbourg, France","author":"European Pharmacopoeia","year":"2019"},{"key":"10.1016\/j.jviromet.2019.01.001_bib0035","series-title":"Monograph 1056. Hepatitis B Vaccine (rDNA). Strasbourg, France","author":"European Pharmacopoeia","year":"2019"},{"key":"10.1016\/j.jviromet.2019.01.001_bib0040","series-title":"Food and Drug Administration. Letter to Inform Manufacturers of the Following Interim Recommendations Pertaining to Viral Vaccine Products That Are Produced in Vero Cells and Investigated for Human Use","author":"FDA","year":"2001"},{"key":"10.1016\/j.jviromet.2019.01.001_bib0045","series-title":"Food and Drug Administration. Guidance for Industry - Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications","author":"FDA","year":"2010"},{"key":"10.1016\/j.jviromet.2019.01.001_bib0050","series-title":"The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Harmonised Tripartite Guideline - Validation of Analytical Procedures: Text and Methodology Q2(R1)","author":"ICH","year":"2005"},{"key":"10.1016\/j.jviromet.2019.01.001_bib0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0165-022X(91)90053-Y","article-title":"Influence of fragment size on DNA quantitation using DNA-binding proteins and a sensor-based analytical system: applications in the testing of biological products","volume":"23","author":"King","year":"1991","journal-title":"J. Biochem. Biophys. Methods"},{"key":"10.1016\/j.jviromet.2019.01.001_bib0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0009-2797(75)90045-9","article-title":"Intermolecular linking and fragmentation of DNA by beta-propiolactone, a monoalkylating carcinogen","volume":"10","author":"Kubinski","year":"1975","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jviromet.2019.01.001_bib0065","first-page":"35","article-title":"Adaptation of the WHO guideline for residual DNA in parenteral vaccines produced on continuous cell lines to a limit for oral vaccines","volume":"123","author":"Lebron","year":"2006","journal-title":"Dev. Biol. (Basel)"},{"key":"10.1016\/j.jviromet.2019.01.001_bib0070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/biol.1995.0034","article-title":"Inactivation of DNA by beta-propiolactone","volume":"23","author":"Perrin","year":"1995","journal-title":"Biologicals"},{"key":"10.1016\/j.jviromet.2019.01.001_bib0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1045-1056(05)80010-7","article-title":"A collaborative study to examine the sensitivity and reproducibility of assays for the detection of DNA in biologicals derived from continuous cell lines","volume":"20","author":"Robertson","year":"1992","journal-title":"Biologicals"},{"key":"10.1016\/j.jviromet.2019.01.001_bib0080","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.biologicals.2009.02.015","article-title":"Issues associated with residual cell-substrate DNA in viral vaccines","volume":"37","author":"Sheng-Fowler","year":"2009","journal-title":"Biologicals"},{"key":"10.1016\/j.jviromet.2019.01.001_bib0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.7150\/ijbs.6.151","article-title":"Tumors induced in mice by direct inoculation of plasmid DNA expressing both activated H-ras and c-myc","volume":"6","author":"Sheng-Fowler","year":"2010","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jviromet.2019.01.001_bib0090","series-title":"General Information Chapter <1130> Nucleic Acid-based Techniques - Approaches for Detecting Trace Nucleic Acids (residual DNA Testing). Rockville, Maryland, USA","article-title":"United States pharmacopeia","author":"USP","year":"2018"},{"key":"10.1016\/j.jviromet.2019.01.001_bib0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/bit.23343","article-title":"Residual DNA analysis in biologics development: review of measurement and quantitation technologies and future directions","volume":"109","author":"Wang","year":"2012","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jviromet.2019.01.001_bib0100","series-title":"World Health Organization, Acceptability of Cell Substrates for Production of Biologicals. Report of a WHO Study Group on Biologicals. Technical Report Series 747","first-page":"1","author":"WHO","year":"1987"},{"key":"10.1016\/j.jviromet.2019.01.001_bib0105","series-title":"World Health Organization, Expert Committee on Biological Standardization. Requirements for the Use of Animal Cells As in Vitro Substrates for the Production of Biologicals. WHO Technical Report Series 878. Forty-seventh Report","author":"WHO","year":"1998"},{"key":"10.1016\/j.jviromet.2019.01.001_bib0110","series-title":"World Health Organization (WHO), Guidelines To Assure The Quality, Safety And Efficacy Of Live Attenuated Rotavirus Vaccines (Oral), Technical Report Series 941","author":"WHO","year":"2007"},{"key":"10.1016\/j.jviromet.2019.01.001_bib0115","author":"WHO","year":"2013"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093418304816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093418304816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:50:48Z","timestamp":1759056648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093418304816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":23,"alternative-id":["S0166093418304816"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2019.01.001","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of the performance of residual host cell DNA assays for viral vaccines produced in Vero cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2019.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}